| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2973150 | The Journal of Heart and Lung Transplantation | 2006 | 7 Pages |
Abstract
The choice of immunosuppression has an impact on the incidence of CAV. In terms of prevention of CAV, MMF is superior to Aza in either combination. A trend toward improved survival in MMF patients was noted. The lower number of rejection episodes in the MMF groups may have contributed to these results.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ingo MD, Bjoern MD, Daniel MD, Sebastian MD, Andreas MD, Sabine MD, Bruno MD, Bruno MD,